1. Home
  2. RMBS vs BIO Comparison

RMBS vs BIO Comparison

Compare RMBS & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMBS
  • BIO
  • Stock Information
  • Founded
  • RMBS 1990
  • BIO 1952
  • Country
  • RMBS United States
  • BIO United States
  • Employees
  • RMBS N/A
  • BIO N/A
  • Industry
  • RMBS Semiconductors
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • RMBS Technology
  • BIO Industrials
  • Exchange
  • RMBS Nasdaq
  • BIO Nasdaq
  • Market Cap
  • RMBS 7.8B
  • BIO 6.6B
  • IPO Year
  • RMBS 1997
  • BIO N/A
  • Fundamental
  • Price
  • RMBS $73.79
  • BIO $272.14
  • Analyst Decision
  • RMBS Strong Buy
  • BIO Strong Buy
  • Analyst Count
  • RMBS 5
  • BIO 4
  • Target Price
  • RMBS $80.60
  • BIO $333.50
  • AVG Volume (30 Days)
  • RMBS 1.4M
  • BIO 342.8K
  • Earning Date
  • RMBS 07-28-2025
  • BIO 07-31-2025
  • Dividend Yield
  • RMBS N/A
  • BIO N/A
  • EPS Growth
  • RMBS 0.94
  • BIO N/A
  • EPS
  • RMBS 2.11
  • BIO 11.49
  • Revenue
  • RMBS $645,488,000.00
  • BIO $2,554,200,000.00
  • Revenue This Year
  • RMBS $26.64
  • BIO N/A
  • Revenue Next Year
  • RMBS $12.99
  • BIO $3.42
  • P/E Ratio
  • RMBS $34.94
  • BIO $24.09
  • Revenue Growth
  • RMBS 35.17
  • BIO N/A
  • 52 Week Low
  • RMBS $37.43
  • BIO $211.43
  • 52 Week High
  • RMBS $76.20
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • RMBS 63.57
  • BIO 60.20
  • Support Level
  • RMBS $69.51
  • BIO $268.39
  • Resistance Level
  • RMBS $76.07
  • BIO $291.87
  • Average True Range (ATR)
  • RMBS 2.89
  • BIO 9.65
  • MACD
  • RMBS 0.61
  • BIO 1.92
  • Stochastic Oscillator
  • RMBS 82.00
  • BIO 63.62

About RMBS Rambus Inc.

Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: